Milder Donald B's Form 4 filing
Inari Medical, Inc. (NARI) · filed Feb 25, 2022
- Accession no.
- 0001562180-22-001946
- Filed
- Feb 25, 2022
- Trade date
- Feb 23-24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $342.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Milder Donald BCIK 0001279660 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Common Stock | SSaleDisposed | −100 | $80.00 | −$8,000 | 3,882,786 | Indirect | |
| Feb 24, 2022 | Common Stock | SSaleDisposed | −1,803 | $80.04F3 | −$144,312.12 | 3,880,983 | Indirect | |
| Feb 24, 2022 | Common Stock | SSaleDisposed | −2,369 | $80.07F4 | −$189,685.83 | 3,878,614 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $80.00 to $80.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $80.00 to $80.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.